[Study tests Varicella-Zoster vaccine for over 60-years-old persons. Protection from Herpes zoster and postherpetic neuralgia].
D000367:Age Factors; D004311:Double-Blind Method; D006562:Herpes Zoster / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D053061:Herpes Zoster Vaccine; D014645:Herpesvirus 3, Human / Q000276:immunology*; D022283:Herpesvirus Vaccines / Q000008:administration & dosage*; D006801:Humans; D015994:Incidence; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D051474:Neuralgia, Postherpetic / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D010919:Placebos; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors
D053061:Herpes Zoster Vaccine; D022283:Herpesvirus Vaccines; D010919:Placebos